Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Dry Powder Inhaler Market Research Report 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Research Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Dry Powder Inhaler Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 Single Dose Dry Powder Inhaler
      • 1.3.3 Multi Dose Dry Powder Inhaler
    • 1.4 Market Segment by Application
      • 1.4.1 Global Dry Powder Inhaler Market Share by Application (2019-2025)
      • 1.4.2 Asthma
      • 1.4.3 Chronic Obstructive Pulmonary Disease
      • 1.4.4 Pulmonary Arterial Hypertension
      • 1.4.5 Others
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Production and Capacity Analysis
      • 2.1.1 Global Dry Powder Inhaler Production Value 2014-2025
      • 2.1.2 Global Dry Powder Inhaler Production 2014-2025
      • 2.1.3 Global Dry Powder Inhaler Capacity 2014-2025
      • 2.1.4 Global Dry Powder Inhaler Marketing Pricing and Trends
    • 2.2 Key Producers Growth Rate (CAGR) 2019-2025
      • 2.2.1 Global Dry Powder Inhaler Market Size CAGR of Key Regions
      • 2.2.2 Global Dry Powder Inhaler Market Share of Key Regions
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Capacity and Production by Manufacturers
      • 3.1.1 Global Dry Powder Inhaler Capacity by Manufacturers
      • 3.1.2 Global Dry Powder Inhaler Production by Manufacturers
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Dry Powder Inhaler Revenue by Manufacturers (2014-2019)
      • 3.2.2 Dry Powder Inhaler Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Dry Powder Inhaler Market Concentration Ratio (CR5 and HHI)
    • 3.3 Dry Powder Inhaler Price by Manufacturers
    • 3.4 Key Manufacturers Dry Powder Inhaler Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Dry Powder Inhaler Market
    • 3.6 Key Manufacturers Dry Powder Inhaler Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Production and Production Value for Each Type
      • 4.1.1 Single Dose Dry Powder Inhaler Production and Production Value (2014-2019)
      • 4.1.2 Multi Dose Dry Powder Inhaler Production and Production Value (2014-2019)
    • 4.2 Global Dry Powder Inhaler Production Market Share by Type
    • 4.3 Global Dry Powder Inhaler Production Value Market Share by Type
    • 4.4 Dry Powder Inhaler Ex-factory Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Dry Powder Inhaler Consumption by Application

    6 Production by Regions

    • 6.1 Global Dry Powder Inhaler Production (History Data) by Regions 2014-2019
    • 6.2 Global Dry Powder Inhaler Production Value (History Data) by Regions
    • 6.3 United States
      • 6.3.1 United States Dry Powder Inhaler Production Growth Rate 2014-2019
      • 6.3.2 United States Dry Powder Inhaler Production Value Growth Rate 2014-2019
      • 6.3.3 Key Players in United States
      • 6.3.4 United States Dry Powder Inhaler Import & Export
    • 6.4 European Union
      • 6.4.1 European Union Dry Powder Inhaler Production Growth Rate 2014-2019
      • 6.4.2 European Union Dry Powder Inhaler Production Value Growth Rate 2014-2019
      • 6.4.3 Key Players in European Union
      • 6.4.4 European Union Dry Powder Inhaler Import & Export
    • 6.5 China
      • 6.5.1 China Dry Powder Inhaler Production Growth Rate 2014-2019
      • 6.5.2 China Dry Powder Inhaler Production Value Growth Rate 2014-2019
      • 6.5.3 Key Players in China
      • 6.5.4 China Dry Powder Inhaler Import & Export
    • 6.6 Rest of World
      • 6.6.1 Japan
      • 6.6.2 Korea
      • 6.6.3 India
      • 6.6.4 Southeast Asia

    7 Dry Powder Inhaler Consumption by Regions

    • 7.1 Global Dry Powder Inhaler Consumption (History Data) by Regions
    • 7.2 United States
      • 7.2.1 United States Dry Powder Inhaler Consumption by Type
      • 7.2.2 United States Dry Powder Inhaler Consumption by Application
    • 7.3 European Union
      • 7.3.1 European Union Dry Powder Inhaler Consumption by Type
      • 7.3.2 European Union Dry Powder Inhaler Consumption by Application
    • 7.4 China
      • 7.4.1 China Dry Powder Inhaler Consumption by Type
      • 7.4.2 China Dry Powder Inhaler Consumption by Application
    • 7.5 Rest of World
      • 7.5.1 Rest of World Dry Powder Inhaler Consumption by Type
      • 7.5.2 Rest of World Dry Powder Inhaler Consumption by Application
      • 7.5.1 Japan
      • 7.5.2 Korea
      • 7.5.3 India
      • 7.5.4 Southeast Asia

    8 Company Profiles

    • 8.1 Astrazeneca
      • 8.1.1 Astrazeneca Company Details
      • 8.1.2 Company Description and Business Overview
      • 8.1.3 Production and Revenue of Dry Powder Inhaler
      • 8.1.4 Dry Powder Inhaler Product Introduction
      • 8.1.5 Astrazeneca Recent Development
    • 8.2 3M
      • 8.2.1 3M Company Details
      • 8.2.2 Company Description and Business Overview
      • 8.2.3 Production and Revenue of Dry Powder Inhaler
      • 8.2.4 Dry Powder Inhaler Product Introduction
      • 8.2.5 3M Recent Development
    • 8.3 GlaxoSmithKline
      • 8.3.1 GlaxoSmithKline Company Details
      • 8.3.2 Company Description and Business Overview
      • 8.3.3 Production and Revenue of Dry Powder Inhaler
      • 8.3.4 Dry Powder Inhaler Product Introduction
      • 8.3.5 GlaxoSmithKline Recent Development
    • 8.4 Novartis
      • 8.4.1 Novartis Company Details
      • 8.4.2 Company Description and Business Overview
      • 8.4.3 Production and Revenue of Dry Powder Inhaler
      • 8.4.4 Dry Powder Inhaler Product Introduction
      • 8.4.5 Novartis Recent Development
    • 8.5 Cipla
      • 8.5.1 Cipla Company Details
      • 8.5.2 Company Description and Business Overview
      • 8.5.3 Production and Revenue of Dry Powder Inhaler
      • 8.5.4 Dry Powder Inhaler Product Introduction
      • 8.5.5 Cipla Recent Development
    • 8.6 Teva
      • 8.6.1 Teva Company Details
      • 8.6.2 Company Description and Business Overview
      • 8.6.3 Production and Revenue of Dry Powder Inhaler
      • 8.6.4 Dry Powder Inhaler Product Introduction
      • 8.6.5 Teva Recent Development
    • 8.7 Boehringer Ingelheim
      • 8.7.1 Boehringer Ingelheim Company Details
      • 8.7.2 Company Description and Business Overview
      • 8.7.3 Production and Revenue of Dry Powder Inhaler
      • 8.7.4 Dry Powder Inhaler Product Introduction
      • 8.7.5 Boehringer Ingelheim Recent Development
    • 8.8 Chiesi Farmaceutici
      • 8.8.1 Chiesi Farmaceutici Company Details
      • 8.8.2 Company Description and Business Overview
      • 8.8.3 Production and Revenue of Dry Powder Inhaler
      • 8.8.4 Dry Powder Inhaler Product Introduction
      • 8.8.5 Chiesi Farmaceutici Recent Development
    • 8.9 MannKind
      • 8.9.1 MannKind Company Details
      • 8.9.2 Company Description and Business Overview
      • 8.9.3 Production and Revenue of Dry Powder Inhaler
      • 8.9.4 Dry Powder Inhaler Product Introduction
      • 8.9.5 MannKind Recent Development
    • 8.10 Vectura
      • 8.10.1 Vectura Company Details
      • 8.10.2 Company Description and Business Overview
      • 8.10.3 Production and Revenue of Dry Powder Inhaler
      • 8.10.4 Dry Powder Inhaler Product Introduction
      • 8.10.5 Vectura Recent Development

    9 Market Forecast

    • 9.1 Global Market Size Forecast
      • 9.1.1 Global Dry Powder Inhaler Capacity, Production Forecast 2019-2025
      • 9.1.2 Global Dry Powder Inhaler Production Value Forecast 2019-2025
    • 9.2 Market Forecast by Regions
      • 9.2.1 Global Dry Powder Inhaler Production and Value Forecast by Regions 2019-2025
      • 9.2.2 Global Dry Powder Inhaler Consumption Forecast by Regions 2019-2025
    • 9.3 United States
      • 9.3.1 Production and Value Forecast in United States
      • 9.3.2 Consumption Forecast in United States
    • 9.4 European Union
      • 9.4.1 Production and Value Forecast in European Union
      • 9.4.2 Consumption Forecast in European Union
    • 9.5 China
      • 9.5.1 Production and Value Forecast in China
      • 9.5.2 Consumption Forecast in China
    • 9.6 Rest of World
      • 9.6.1 Japan
      • 9.6.2 Korea
      • 9.6.3 India
      • 9.6.4 Southeast Asia
    • 9.7 Forecast by Type
      • 9.7.1 Global Dry Powder Inhaler Production Forecast by Type
      • 9.7.2 Global Dry Powder Inhaler Production Value Forecast by Type
    • 9.8 Consumption Forecast by Application

    10 Value Chain and Sales Channels Analysis

    • 10.1 Value Chain Analysis
    • 10.2 Sales Channels Analysis
      • 10.2.1 Dry Powder Inhaler Sales Channels
      • 10.2.2 Dry Powder Inhaler Distributors
    • 10.3 Dry Powder Inhaler Customers

    11 Opportunities & Challenges, Threat and Affecting Factors

    • 11.1 Market Opportunities
    • 11.2 Market Challenges
    • 11.3 Porter's Five Forces Analysis

    12 Key Findings

      13 Appendix

      • 13.1 Research Methodology
        • 13.1.1 Methodology/Research Approach
          • 13.1.1.1 Research Programs/Design
          • 13.1.1.2 Market Size Estimation
          • 13.1.1.3 Market Breakdown and Data Triangulation
        • 13.1.2 Data Source
          • 13.1.2.1 Secondary Sources
          • 13.1.2.2 Primary Sources
      • 13.2 Author Details

      A dry-powder inhaler (DPI) is a device that delivers medication to the lungs in the form of a dry powder. DPIs are commonly used to treat respiratory diseases such as asthma, bronchitis, emphysema and COPD although DPIs (such as inhalable insulin Afrezza) have also been used in the treatment of diabetes mellitus. DPIs are an alternative to the aerosol-based inhalers commonly called metered-dose inhaler (or MDI).
      Chronic obstructive pulmonary disease will continue to be the fast-expanding application of dry powder inhalers.
      In 2019, the market size of Dry Powder Inhaler is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
      In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Dry Powder Inhaler.

      This report studies the global market size of Dry Powder Inhaler, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
      This study presents the Dry Powder Inhaler production, revenue, market share and growth rate for each key company, and also covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
      For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

      In global market, the following companies are covered:
      Astrazeneca
      3M
      GlaxoSmithKline
      Novartis
      Cipla
      Teva
      Boehringer Ingelheim
      Chiesi Farmaceutici
      MannKind
      Vectura

      Market Segment by Product Type
      Single Dose Dry Powder Inhaler
      Multi Dose Dry Powder Inhaler

      Market Segment by Application
      Asthma
      Chronic Obstructive Pulmonary Disease
      Pulmonary Arterial Hypertension
      Others

      Key Regions split in this report: breakdown data for each region.
      United States
      China
      European Union
      Rest of World (Japan, Korea, India and Southeast Asia)

      The study objectives are:
      To analyze and research the Dry Powder Inhaler status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
      To present the key Dry Powder Inhaler manufacturers, presenting the sales, revenue, market share, and recent development for key players.
      To split the breakdown data by regions, type, companies and applications
      To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
      To identify significant trends, drivers, influence factors in global and regions
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

      In this study, the years considered to estimate the market size of Dry Powder Inhaler are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      Buy now